News

Washington -- According to Komal Pandya, two derivatives of green tea -- caffeine and epigallocatechin-3-gallate (EGCG) -- control UV damage after it has occurred.

London - J. Meirion Thomas, M.S., F.R.C.P., F.R.C.S., set out in a recent study to confirm that wide excision margin provides no advantage over narrow excision margin in melanoma. But, after studying 900 patients in the decade-long study, he found the opposite is true.

Data on new lesion development during follow-up shows drug is effective in simultaneous control of both conditions

Washington - The therapy of choice for the treatment of toenail onychomycosis remains continuous doses of terbinafine (Lamisil), according to Erin Warshaw, M.D. In certain situations, however, pulse dosing may play a role.

Washington - Results of a multistudy analysis reinforce the efficacy of subcutaneous etanercept (Enbrel, Amgen) for inducing rapid and sustained improvement in patients with chronic plaque psoriasis, said Kenneth Gordon, M.D., at the annual meeting of the American Academy of Dermatology.

Boca Raton, Fla. - Contact dermatitis from topical medications is the most common type of adverse drug reaction, and allergic contact dermatitis is the most common and most important form of contact dermatitis induced by topical drugs, according to James S. Taylor, M.D., head of the industrial dermatology section of the department of dermatology at the Cleveland Clinic Foundation in Cleveland. "Patients with medicament contact dermatitis usually have a good prognosis, but with a propensity for relapse," he said.

Washington - Pimecrolimus cream 1 percent showed better local tolerability than tacrolimus ointment 0.03 percent in pediatric patients with moderate atopic dermatitis, and the patients or their primary caregivers rated most of the formulation attributes of the pimecrolimus cream as being significantly better than those of the tacrolimus ointment, according to a recent Phase IV study presented at the American Academy of Dermatology annual meeting.

Washington - Oral tazarotene offers rapid and durable clinical improvement in difficult-to-treat psoriatic lesions on the elbows and knees, said Sewon Kang, M.D., at the 62nd annual meeting of the American Academy of Dermatology.

Dallas - Most community-acquired methicillin-resistant staphylococcus aureus (MRSA) skin and soft tissue abscesses smaller than 5 cm can be managed with standard incision and drainage, without the need for antibiotic therapy, according to a new study.

Pulse doses of oral agent may help stabilize inflammatory acne

Washington, D.C. - In a recent 10-week, three-dose phase II trial of inflaximab (Remicade), 87.9 percent of the 250 participants achieved PASI 75, while 58 percent achieved PASI 90 at the 10-week mark.

Dr. Bob has a large, mostly medical, dermatology practice. The practice is divided almost equally into patients whose health care insurance is provided by managed care organizations and those whose insurance is provided by federally insured policies with either Medicare or Medicaid.

Doctors may be fined or expelled from the Medicare program if they charge patients extra for providing a deluxe version of services already covered by Medicare, according to the New York Times.

Seattle - Reducing medical errors can be greatly facilitated by bringing state-of-the-art information technology into offices, clinics, pharmacies, and hospitals, according to Paul Tang, M.D. "The status quo is unacceptable," he said. "We can't manage the amount of paper we have now as healthcare professionals."

Washington - Investigators developing a rosacea-specific quality-of-life instrument (RosaQoL) have demonstrated its reliability and validity and have begun testing its responsiveness to changes in rosacea severity, said Suephy C. Chen, M.D., M.S., at the annual meeting of the American Academy of Dermatology.

More than half of all Americans are symptomatic of highly contagious, unsightly, and often difficult-to-cure nail fungus and infections, and may potentially pass them along to others by sharing nail tools, according to a survey on nail hygiene habits.

Prescription drug makers will be required within two years to put bar codes on packaging in an effort to reduce potentially dangerous dispensing errors in hospitals, U.S. health officials said. The bar codes are meant to enable nurses and other healthcare workers to electronically verify that they are giving the right drug at the right dose at the right time. The Bush administration published a final regulation on the bar-coding requirement in February. Under the requirement, each bar code must contain a drug's unique identification number. Companies also may include information on the product's lot number and expiration date. A nurse using the system would scan a patient's identification bracelet and then the drug label, and then a computer would compare the information. An error message would appear if the drug, dose, or time of dose were incorrect.

Before adding an allied health professional to your practice, keep in mind these practical suggestions from four practice management experts on how to identify and attract prime candidates:

The Food and Drug Administration said consumers should stay away from Green Hornet, a liquid pitched as an herbal form of the illegal drug ecstasy. The agency has received reports of four teens taking Green Hornet and being hospitalized for seizures, excessive heart rates, severe body rashes, and high blood pressure. The FDA said the herbal liquid, sold on the Internet and in stores, is illegal because it contains active drugs not listed on the label and because Green Hornet claims to be an alternative to a street drug.

Business owners across the country are facing big hikes in worker's compensation rates. In Alaska, worker's compensation insurance rates will rise more than 20 percent in 2004.

McClellan takes over at CMS; tackles medicare reforms, drug benefits

Recognizing specific conditions or personality traits may help reduce your exposure

Washington - Timely diagnosis of juvenile dermatomyositis is critical because early aggressive management with immunosuppressive agents, even for patients with amyopathic disease, is the best method for preventing calcinosis that is a source of significant morbidity for these children, said Amy S. Paller, M.D., at the annual meeting of the American Academy of Dermatology.

Washington - While hair loss may become more acceptable with increasing age, for some older people it is psychologically devastating and adds to the string of losses they may encounter, said Janet L. Roberts, M.D., at the annual meeting of the American Academy of Dermatology.

Washington - Intradermal botulinum toxin type A (Botox) for the treatment of primary axillary hyperhidrosis produces a durable effect, with nearly half of patients requiring only one treatment over a one-year period, according to study data released at the annual meeting of the American Academy of Dermatology here.

Waikoloa, Hawaii - The increase in the number of topical anesthesia options available mandates that dermatologists consider how they compare with respect to efficacy, safety, and patient convenience when selecting an agent to minimize the pain of a cutaneous procedure, said Dina N. Anderson, M.D., at the recent annual Hawaii Dermatology Seminar.

Los Angeles - Use of the topical skin adhesive 2-octylcyanoacrylate (Dermabond, Closure Medical) for final wound closure makes life much easier for surgeons and their patients, said Susan E. Downey, M.D.

Washington - The phrase "what is old is new again" aptly describes the current status of antimicrobial dressings, which, thanks to a new generation of products, are making a comeback in the woundcare arena, said Marketa Limova, M.D., at the annual meeting of the American Academy of Dermatology.

Plans and employers are called to promote health search literacy on the 'Net

Washington - Treatment of melasma has advanced significantly with the availability of new hydroquinone combination therapies that can produce clearing safely and more rapidly than single-agent regimens, said Valerie D. Callender, M.D., at the annual meeting of the American Academy of Dermatology.